Obesity Medications
Definition of Obesity: More than half of the U.S. population is overweight. But being obese is different from being overweight. An individual is considered obese when weight is 20% (25% in women) or more over the maximum desirable for their height. When an adult is more than 100 pounds overweight, it is considered morbid obesity.
Obesity is also defined as a BMI (body mass index) over 30 kg/m2. Patients with a BMI between 25 and 29.9 are considered overweight, but not obese. See also diet and calories.
See also: Weight Loss
Drugs associated with Obesity
The following drugs and medications are in some way related to, or used in the treatment of Obesity.
This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Tenuate (More...)
 generic name: diethylpropion class: anorexiants, CNS stimulants | 8 review(s) | Rate It! | 9.8 |
Tenuate Dospan (More...)
generic name: diethylpropion class: anorexiants, CNS stimulants | 2 review(s) | Rate It! | 9.0 |
Bontril SR (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 9 review(s) | Rate It! | 8.8 |
Topamax (Pro, More...)
generic name: topiramate class: carbonic anhydrase inhibitor anticonvulsants | 2 review(s) | Rate It! | 8.5 |
Meridia (Pro, More...)
generic name: sibutramine class: anorexiants | 23 review(s) | Rate It! | 8.3 |
Xenical (Pro, More...)
generic name: orlistat class: peripherally acting antiobesity agents | 9 review(s) | Rate It! | 8.0 |
Alli (More...)
generic name: orlistat class: peripherally acting antiobesity agents | 7 review(s) | Rate It! | 8.0 |
Phendiet (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 1 review(s) | Rate It! | 8.0 |
Pristiq (Pro, More...)
generic name: desvenlafaxine class: SSNRI antidepressants | 1 review(s) | Rate It! | 8.0 |
Bontril PDM (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 0 review(s) | Rate It! | 8.0 |
Bontril Slow-Release (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 4 review(s) | Rate It! | 7.0 |
Didrex (Pro, More...)
generic name: benzphetamine class: anorexiants, CNS stimulants | 1 review(s) | Rate It! | 5.0 |
Topamax Sprinkle (More...)
generic name: topiramate class: carbonic anhydrase inhibitor anticonvulsants | 0 review(s) | Not rated - Be the first |
Statobex (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Desoxyn Gradumet (More...)
generic name: methamphetamine class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Mazanor (More...)
generic name: mazindol class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Desoxyn (Pro, More...)
generic name: methamphetamine class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Appecon (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Anorex-SR (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Melfiat (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Obezine (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Sanorex (More...)
generic name: mazindol class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Prelu-2 TR (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Prelu-2 (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Plegine (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Adipost (More...)
generic name: phendimetrazine class: anorexiants, CNS stimulants | 0 review(s) | Not rated - Be the first |
Obesity Medications in the Pipeline
Zimulti (rimonabant)
- November 6, 2008
Sanofi-aventis to Discontinue all Clinical Trials with rimonabant - November 14, 2007
Rimonabant - Regulatory Update in Europe - July 19, 2007
Committee for Medicinal Products for Human Use Post-authorisation
Summary of Positive Opinion for Acomplia/Zimulti - June 29, 2007
Rimonabant Regulatory Update in the United States - June 14, 2007
Weight Loss Drug Rimonabant Can Cause Serious Physical and
Psychological Harm and Birth Defects, Public Citizen Tells FDA - June 13, 2007
FDA Advisory Committee Did Not Recommend Approval of Rimonabant
(Zimulti) for Use in Obese and Overweight Patients With Associated
Risks Factors - March 26, 2007
Rimonabant USA: Update - March 26, 2007
Sanofi-aventis Acknowledges FDA Announcement of an Advisory Committee Meeting for rimonabant - February 12, 2007
Rimonabant USA: Update - December 8, 2006
Rimonabant Update in the United States - February 17, 2006
Sanofi-aventis Received from the FDA an Approvable Letter for Rimonabant for Weight Management and a Non Approvable Letter for Smoking Cessation - June 23, 2005
Rimonabant Accepted for Filing By the FDA
See also
Learn more about Obesity
Medical encyclopedia results for:
Browse drugs by condition:
